Gold nanoclusters offer route to better vaccines

Hepatitis E, a viral infection which attacks the liver, is contracted by around 20 million people each year and results in 57,000 deaths annually. Although a vaccine has been available in China since 2011, it has yet to gain worldwide approval due to a lack of detailed safety data.

Now, a group of researchers, led by Guangjun Nie of the National Center for Nanoscience and Technology in Beijing, has found a way of delivering the vaccine using gold-nanoparticles, which could lead to safer and more effective protection from infection.

This article provides a link to coverage by Chemistry World.